Terry D. Crawford

机构：Genesys (United States) · ORCID：0000-0003-4663-4116

发表论文 25 篇 · 总被引 1304 次 · h-index 19

代表论文

• Disrupting Acetyl-Lysine Recognition: Progress in the Development of Bromodomain Inhibitors (2015 · Journal of Medicinal Chemistry · 被引 190)
• GNE-781, A Highly Advanced Potent and Selective Bromodomain Inhibitor of Cyclic Adenosine Monophosphate Response Element Binding Protein, Binding Protein (CBP) (2017 · Journal of Medicinal Chemistry · 被引 136)
• Diving into the Water: Inducible Binding Conformations for BRD4, TAF1(2), BRD9, and CECR2 Bromodomains (2016 · Journal of Medicinal Chemistry · 被引 119)
• Fragment-Based Discovery of a Selective and Cell-Active Benzodiazepinone CBP/EP300 Bromodomain Inhibitor (CPI-637) (2016 · ACS Medicinal Chemistry Letters · 被引 114)
• Discovery of a Potent and Selective in Vivo Probe (GNE-272) for the Bromodomains of CBP/EP300 (2016 · Journal of Medicinal Chemistry · 被引 96)
• Discovery of Small-Molecule Inhibitors of Ubiquitin Specific Protease 7 (USP7) Using Integrated NMR and in Silico Techniques (2017 · Journal of Medicinal Chemistry · 被引 91)